Candida lusitaniae is considered an emerging opportunistic pathogen that most frequently affects immunocompromised patients with some comorbidity.

2024年5月12日 · Candida lusitaniae is one of the rare or uncommon fungal yeast pathogens that is now gaining importance as an emerging cause of candidemia. What you need to know

Candida lusitaniae is an emerging opportunistic pathogen in immunocompromised hosts and hospitalized patients. However, the incidence is low in immunocompetent hosts. Because of their characteristic similarities, C. lusitaniae may be confused with ...

C. lusitaniae appears to be susceptible to amphotericin B, azole antifungal agents, and, to a lesser extent, flucytosine.

2023年7月10日 · Candida (Clavispora) lusitaniae is a rare, emerging non-albicans Candida species that can cause life-threatening invasive infections, spread within hospital settings, and rapidly acquire antifungal drug resistance, including multidrug resistance.

2003年1月15日 · Because no comprehensive review has been published recently, we provide a case report and a literature review of C. lusitaniae infection to update and better characterize the illness in the era of azole availability and standardized methodologies for …

Candida lusitaniae is an extremely rare but emerging nosocomial infection. We describe a 55-year-old female who was found to have bronchioloalveolar carcinoma and coexistent C. lusitaniae pleuropulmonary infection.